Projects

Criticl care quality indicators analytics application

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2015 - 2018

Project Lead

Dr. Tony D.S. Raj

Authors

Dr. Tony D.S. Raj, Dr. Kedar Radhakrishna

Project Status

completed

Project Type

Indian Society of Critical Care Medicine, Mumbai